Dems reintroduce clinical trial transparency bill

05/23/2013 | PharmaLive.com

Four House Democrats reintroduced a bill that would require overseas clinical trials to be registered and reported in the U.S. at ClinicalTrials.gov if the trials are in support of a drug to be sold in the U.S.

View Full Article in:

PharmaLive.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY